| Treasury Building, Lower Grand Canal St. | Phone: +353-1-709-4000 |
| Dublin | Fax: +353-1-709-4700 |
| Ireland | 
Map This Company |
Elan Corporation, plc Rankings
Company Description
Elan has brain and nerve conditions on its mind. The biotech company is focused on the development of pharmaceuticals for neurological and autoimmune disorders. Its product offerings include anti-infectives and treatments for degenerative diseases. Elan's future fortunes rely largely on the success of beleaguered multiple sclerosis (MS) and Crohn's disease therapy Tysabri, a monoclonal antibody (single-source protein) therapy it co-developed with
Elan Corporation, plc Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Irish: ELA Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 1,219 |
Executives
28 executives listed for Elan Corporation, plc's Dublin, Ireland location.
| Chairman | Robert Ingram | |
|---|---|---|
| CEO and Director | G. Kelly Martin | |
| President | Carlos Paya |